The latest closing stock price for Aclaris Therapeutics as of January 17, 2025 is 2.57.
An investor who bought $1,000 worth of Aclaris Therapeutics stock at the IPO in 2015 would have $-767 today, roughly -1 times their original investment - a -14.96% compound annual growth rate over 9 years.
The all-time high Aclaris Therapeutics stock closing price was 32.99 on April 17, 2017.
The Aclaris Therapeutics 52-week high stock price is 5.17, which is 101.2% above the current share price.
The Aclaris Therapeutics 52-week low stock price is 0.95, which is 63% below the current share price.
The average Aclaris Therapeutics stock price for the last 52 weeks is 1.59.
An investor who bought $1,000 worth of Aclaris Therapeutics stock at the IPO in 2015 would have $-767 today, roughly -1 times their original investment - a -14.96% compound annual growth rate over 9 years.
The all-time high Aclaris Therapeutics stock closing price was 32.99 on April 17, 2017.
The Aclaris Therapeutics 52-week high stock price is 5.17, which is 101.2% above the current share price.
The Aclaris Therapeutics 52-week low stock price is 0.95, which is 63% below the current share price.
The average Aclaris Therapeutics stock price for the last 52 weeks is 1.59.